Advised by Potomac Transactions, Herbarom Group, leader in natural ingredients and nutraceutical contract manufacturing, opens its capital to BNP and BPI to accelerate its growth

Managed by Luc Ardouvin, Herbarom Group is positioned as a leader in natural ingredients and nutraceutical processing with two entities: 

Herbarom Laboratoire produces essential oils and plant extracts with historical chains of aromatic plants from its home region Drôme (lavender, chamomile, angelica etc.) for the cosmetic, animal and human health sectors. The company offers tailor-made active ingredients and innovative concepts, rapidly available on the market. 

Phytéo Laboratoire, nutraceutical contract manufacturing, this entity is the undisputed leader in liquid and dry galenic forms with a unique quality by offering its sourcing of plant solutions from Herbarom Laboratoire. 

The ambition of Herbarom Group is to become a European leader in natural ingredients and nutraceuticals through an ambitious strategy of organic and external growth. Herbarom has already made three acquisitions in the last five years, the last one in 2021, Akémia bio. Today, the Group has a revenue of more than €50 million. 

Eager to support a Group with unique expertise positioned in high-growth markets and firmly anchored in its home region of the Drôme, BPI France and BNP Paribas Développement have taken a minority interest in the company to support its growth strategy. In addition to a financial support, the two leading institutional investors also bring a powerful French and international network. 

Second transaction this year in the orthopedic sector for Potomac, advising on the sale of Teknimed, a leader in biomaterials, to the private equity firm Essling Capital

Founded in 1990 in Toulouse (France), the European capital of aeronautics, Teknimed is a leader in biomaterials with a unique expertise in orthopedic cements used to fix implants such as hips, knees, shoulders, etc.

Teknimed develops, manufactures and markets worldwide a full and innovative biomaterial product portfolio for orthopedic surgeries and sports medicine. The portfolio includes orthopedic cements, bone substitutes, resorbable polymers and implantable textiles.

After the intra-family transaction in 2015 between Alain Leonard and his daughter Carole financed by the Apax, BPI and Crédit Mutuelle investment funds, Essling Capital is taking over control of Teknimed alongside its CEO, Carole Leonard.

With a unique expertise in biomaterials and a solid growing market, the strategy is to accelerate the international development as well as the development of the OEM business, organically and by acquisitions.

Potomac Transactions is an investment bank based in Paris specialized in the healthcare sector, advising its clients on long-term strategies for acquisitions, divestitures or growth financing in France and abroad. Potomac is active in all segments of the healthcare sector. In the specific orthopedic sector, Potomac has one of the best financial expertises in France, with a lot of transactions year after year. In addition to the two Teknimed transactions in 2015 and 2021, below few recent transactions to illustrate this strong expertise

– Current financial advisor to the Mediliant Group on its acquisition strategy with two acquisitions already completed in the United States in 2020 and 2021 to become a leading contract manufacturer of orthopedic implants in the extremity segment; Pennsylvania-based MDI and Indiana-based CTE.

– Financial Advisor to the founding shareholders of Landanger Group, the French leader in surgical instrumentation, in their opening of capital in 2019 to the prvate equity firm 21 Invest.

– Financial Advisor to Ekkio Capital in the 2018 acquisition of FX Solutions. FX solutions is a specialist in shoulder implants, located both in France and the United States

 

Second transaction this year in the orthopedic sector for Potomac, advising on the sale of Teknimed, a leader in biomaterials, to the private equity firm Essling Capital

Founded in 1990 in Toulouse (France), the European capital of aeronautics, Teknimed is a leader in biomaterials with a unique expertise in orthopedic cements used to fix implants such as hips, knees, shoulders, etc.

Teknimed develops, manufactures and markets worldwide a full and innovative biomaterial product portfolio for orthopedic surgeries and sports medicine. The portfolio includes orthopedic cements, bone substitutes, resorbable polymers and implantable textiles.

After the intra-family transaction in 2015 between Alain Leonard and his daughter Carole financed by the Apax, BPI and Crédit Mutuelle investment funds, Essling Capital is taking over control of Teknimed alongside its CEO, Carole Leonard.

With a unique expertise in biomaterials and a solid growing market, the strategy is to accelerate the international development as well as the development of the OEM business, organically and by acquisitions.

Potomac Transactions is an investment bank based in Paris specialized in the healthcare sector, advising its clients on long-term strategies for acquisitions, divestitures or growth financing in France and abroad. Potomac is active in all segments of the healthcare sector. In the specific orthopedic sector, Potomac has one of the best financial expertises in France, with a lot of transactions year after year. In addition to the two Teknimed transactions in 2015 and 2021, below few recent transactions to illustrate this strong expertise

– Current financial advisor to the Mediliant Group on its acquisition strategy with two acquisitions already completed in the United States in 2020 and 2021 to become a leading contract manufacturer of orthopedic implants in the extremity segment; Pennsylvania-based MDI and Indiana-based CTE.

– Financial Advisor to the founding shareholders of Landanger Group, the French leader in surgical instrumentation, in their opening of capital in 2019 to the prvate equity firm 21 Invest.

– Financial Advisor to Ekkio Capital in the 2018 acquisition of FX Solutions. FX solutions is a specialist in shoulder implants, located both in France and the United States

 

Potomac Transactions advises the sale of Astier Demarest, a french leading company in natural ingredients, to Robertet Group

Founded in 1880 in Grasse (France), the world’s capital of perfume, Astier Demarest (“AD”) is a leader in the sourcing and distribution of aromatic and natural raw materials with strategic positions in essential oils such as vetiver, neroli or ginger. 

Over the past 80 years, AD has developed transparent worldwide supply chains while promoting responsible, ethical and organic production. From Grasse, the company supplies all the world leaders in the flavour and fragrance, cosmetics and aromatherapy sectors. AD has also developed an expertise in synthetic ingredients with historical partnerships with leading manufacturers such as Firmenich (DRT)Emerald Kalama or Kuraray 

Managed by François and Bruno Destoumieux, AD generates more than €30 million in revenues. 

Advised by Potomac Transactions (www.potomac.fr), its 2nd transaction in the natural ingredients sector this year, Astier Demarest joins the Robertet Group. 

Founded in 1850 in Grasse, the Robertet Group is a world leader in natural raw materials and perfumes & flavors, strategically integrating the entire value chain to offer a unique quality to customers. With a worldwide presence, the group generates more than €540 million in revenues. 

Potomac is proud to have advised Laure Ducroux, the passionate entrepreneur behind Laboratoires Laudavie (Calmosine) sold to Havea

Potomac advises the Swiss orthopedic manufacturer Mediliant in its implantation in the US through the acquisition of Medical Device & Implants, a specialist in extremity implants

Potomac is pleased to advise again Ekkio Capital for it second investment in the orthopedic sector, Mediliant the swiss leading contract manufacturer